A3P Biomedical

📍 Stockholm, Sweden🗓 Founded 2018👥 36 employees💰 Last funded Jun 2021
Biotechnology Research🌐 a3p.com
Website LinkedIn
The commercially available Stockholm3- test, is a blood-test for early detection of prostate cancer. A3P Biomedical’s Stockholm3 test, combines protein markers, genetic markers and clinical data with an advanced algorithm in order to detect aggressive prostate cancer at early stage.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in A3P Biomedical?
A3P Biomedical has 1 investors on record on gritt.io, 1 mid-stage.
When did A3P Biomedical last raise funding?
The most recent investment in A3P Biomedical recorded on gritt.io was in June 2021.
When was A3P Biomedical founded?
A3P Biomedical was founded in 2018.
What industry is A3P Biomedical in?
A3P Biomedical operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is A3P Biomedical based?
A3P Biomedical is headquartered in Stockholm, Sweden.